Here we briefly overview the discovery, tissue distribution, and subcellular localization of HSD17B13 and highlight its important role in promoting the pathogenesis of NAFLD/NASH in both experimental animal models and patients. This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatohepatitis.